{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:22:06Z","timestamp":1795029726519,"version":"4.10.2"},"reference-count":50,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/14712598.2021.1931678","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:21:02Z","timestamp":1621441262000},"page":"999-1011","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Eptinezumab for the treatment of migraine"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1591-7703","authenticated-orcid":false,"given":"Valerio","family":"Spuntarelli","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-298X","authenticated-orcid":false,"given":"Andrea","family":"Negro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy"},{"name":"Emergency Department, Regional Referral Headache Centre, Sant\u2019Andrea Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6038-8874","authenticated-orcid":false,"given":"Michelangelo","family":"Luciani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6655-9905","authenticated-orcid":false,"given":"Enrico","family":"Bentivegna","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-4128","authenticated-orcid":false,"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy"},{"name":"Emergency Department, Regional Referral Headache Centre, Sant\u2019Andrea Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"crossref","unstructured":"Headache classification committee of the International Headache Society (IHS) the international classification of headache disorders. 3rd Ed. Cephalalgia. 2018;Vol. 38:1\u2013211","DOI":"10.1177\/0333102417738202"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0787-1"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-011-0388-3"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-47"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30322-3"},{"issue":"11","key":"cit0006","first-page":"703","volume":"17","author":"Linde M","year":"2018","journal-title":"Eur J Neurol"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.07.021"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30478-1"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183717"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0003-1"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2016.1154042"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01111-8"},{"issue":"12","key":"cit0013","first-page":"1401","volume":"15","author":"Negro A","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-017-0628-6"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-010-0457-7"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.681044"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1618830"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30234-9"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32544-7"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1111\/head.13302"},{"key":"cit0021","unstructured":"FDA approved drug products: VYEPTITM (eptinezumab-jjmr) injection, for intravenous use. [cited 2021 May 23]. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761119s000lbl.pdf"},{"key":"cit0022","unstructured":"Safety tolerability and pharmacokinetics of ALD403. [cited 2021 May 23]. Available at: https:\/\/clinicaltrials.gov\/NCT01579383."},{"key":"cit0023","unstructured":"Safety, efficacy and pharmacokinetics of ALD403. [cited 2021 May 23]. Available from: https:\/\/clinicaltrials.gov\/NCT01772524"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70209-1"},{"key":"cit0025","unstructured":"a multicenter assessment of ALD403 in chronic migraine. Available from ClinicalTrials.gov Identifier: NCT02275117"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419858355"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420941839"},{"key":"cit0028","unstructured":"A multicenter assessment of ALD403 in Frequent Episodic Migraine (PROMISE 1) ClinicalTrials.gov Identifier: NCT02559895"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420905132"},{"key":"cit0030","unstructured":"Evaluation of ALD403 (Eptinezumab) in the prevention of chronic migraine (PROMISE 2) - ClinicalTrials.gov Identifier: NCT02974153"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009169"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01186-3"},{"key":"cit0033","unstructured":"Evaluate efficacy & safety of eptinezumab administered intravenously in subjects experiencing acute attack of migraine (RELIEF). [cited 2021 May 23]. Available at: https:\/\/clinicaltrials.gov\/NCT04152083."},{"key":"cit0034","unstructured":"An open label trial of ALD403 (Eptinezumab) in chronic migraine (PREVAIL) ClinicalTrials.gov Identifier: NCT02985398"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0003-1"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2018.1552939"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1703531"},{"key":"cit0038","unstructured":"Ibekwe A,\u00a0Perras C,\u00a0Mierzwinski-Urban M. Monoclonal antibodies to prevent migraine headaches CADTH issues in emerging health technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 167"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1415671"},{"issue":"2","key":"cit0040","first-page":"115","volume":"77","author":"Krymchantowski AV","year":"2019","journal-title":"Migraine treatment: the doors for the future are open, but with caution and prudence. Arq Neuropsiquiatr"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1556465"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.115.135665"},{"issue":"5","key":"cit0043","volume":"21","author":"Fei X","year":"2012","journal-title":"Adv Clin Exp Med"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0816-0"},{"issue":"1","key":"cit0045","first-page":"92.","volume":"20","author":"Agostoni EC","year":"2019","journal-title":"Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2019.55.11.3069864"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01300-4"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01220-y"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.567"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01111-8"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2021.1931678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T17:34:44Z","timestamp":1627320884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2021.1931678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/14712598.2021.1931678"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2021.1931678","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}